# Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion–Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-of-pemetrexed-based-chemotherapy-in-patients-with-ros1-fusion-positive/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yen‐Fu Chen,Min‐Shu Hsieh,Shang‐Gin Wu,Yih‐Leong Chang,Chong‐Jen Yu,James Chih‐Hsin Yang,Pan‐Chyr Yang,Jin‐Yuan Shih |
| Citations | 79 |
| DOI | 10.1016/j.jtho.2016.03.022 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2340583741 |
| PMID | 27094798 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Shang‐Gin Wu](https://scholariq.org/researchers/shang-gin-wu/)
- [Min‐Shu Hsieh](https://scholariq.org/researchers/min-shu-hsieh/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.